News

IDIBELL participates in the COST BESTPRAC meeting held in Belgrade, Serbia

The 10th BESTPRAC Working Group meeting was held from September 24-25 at the Faculty of Electrical Engineering, University of Belgrade, Serbia and gathered over 100 people from different European countries. IDIBELL attended the meeting as part of the action plan to boost its internationalization. COST BESTPRAC is one of the most relevant networks of research […]

Leer más about IDIBELL participates in the COST BESTPRAC meeting held in Belgrade, Serbia

IDIBELL researchers receive AECC grants on World Cancer Research Day

On the occasion of World Cancer Research Day (WCRD), which takes place every year on September 24th, the Spanish Association Against Cancer (AECC) awarded its 2018 AECC Cancer Research grants. The awards ceremony was chaired by Her Majesty the Queen, as Honorary President of the AECC and the AECC Scientific Foundation. This year, AECC has […]

Leer más about IDIBELL researchers receive AECC grants on World Cancer Research Day

Oncobell organises its first symposium

The 1st Oncobell symposium on “Mechanisms of cancer and new therapeutic strategies” officially introduces the IDIBELL cancer research program at a European level

Leer más about Oncobell organises its first symposium

Cycling for multiple sclerosis

From Reus to Puertollano – 665 kilometres – in 29 and a half hours. This is the result of an epic challenge fulfilled by José María Moya, a relative of a multiple sclerosis (MS) patient. This anonymous citizen decided to undertake a cycling challenge last September 7 and 8 to raise funds for the research […]

Leer más about Cycling for multiple sclerosis

A new epigenetic signature predicts the response to immunotherapy in lung cancer

An article published in The Lancet Respiratory Medicine by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics at the University of Barcelona, proves that a specific pattern of epigenetic alterations in lung cancer predictss whether the tumor will […]

Leer más about A new epigenetic signature predicts the response to immunotherapy in lung cancer

The biochemical signature of the synapse in a model of Down syndrome is identified with high resolution

The study has been based on cutting-edge phosphoproteic techniques, and has been carried out thanks to a grant granted by the La Marató de TV3 Foundation

Leer más about The biochemical signature of the synapse in a model of Down syndrome is identified with high resolution

Early Supper Associated With Breast and Prostate Cancer Risk

People who have their evening meal before 9 pm or wait at least two hours before going to sleep have a 20% lower risk of breast and prostate cancer

Leer más about Early Supper Associated With Breast and Prostate Cancer Risk

Novel Common Genetic Susceptibility Loci for Colorectal Cancer

The IDIBELL colorectal cancer research team, led by Dr. Vïctor Moreno, has contributed to a large-scale study that led to the description of 11 new genetic variants associated with this type of cancer. This study, published in in the Journal of the National Cancer Institute,  provides insight into the architecture of common genetic variation contributing […]

Leer más about Novel Common Genetic Susceptibility Loci for Colorectal Cancer

The Third Warehouse of Biological Information: The RNA Code

The best-known way our cells and tissues store biological information is their genetic code, derived from the DNA sequence (Deoxyribonucleic Acid). During the last two decades, the epigenetic code has been identified as capable of controlling our DNA through a series of chemical tags. Today, an article published in Cell by Manel Esteller, coordinator of […]

Leer más about The Third Warehouse of Biological Information: The RNA Code
Scroll to Top